The Leadership Team at EpimAb Biotherapeutics drives the strategic vision and operational excellence of the company. Comprising the Chief Medical Officer, Chief Financial Officer, and Chief Operations/Business Officer, this team oversees the development and implementation of innovative bi-specific antibody therapies, ensuring alignment with corporate goals, regulatory compliance, and financial sustainability. Their collaborative efforts are crucial for navigating the dynamic biotech landscape and advancing EpimAb's pioneering technologies.
View all